Related Experiment Videos
Detection and classification of neurotoxins using a novel short-term plasticity quantification method
Ghassan Gholmieh1, Spiros Courellis, Saman Fakheri
1Department of Biomedical Engineering, University of Southern California, Hedco Neuroscience Bldg, 3614 Watt Way, Los Angeles, CA 90089-1451, USA. gholmieh@usc.edu
Biosensors & Bioelectronics
|August 28, 2003
Summary
A novel tissue biosensor screens nervous system drugs by analyzing short-term plasticity (STP) in hippocampal slices. This method accurately classifies compounds based on their unique neurochemical profiles using an artificial neural network.
Area of Science:
- Neuroscience
- Biosensor Technology
- Computational Biology
Background:
- Screening neuroactive compounds is crucial for drug discovery.
- Existing methods for assessing neural function are often time-consuming.
- Short-term plasticity (STP) in hippocampal slices offers a sensitive measure of neural response.
Purpose of the Study:
- To develop and validate a tissue-based biosensor for rapid screening of neuroactive chemical compounds.
- To establish a novel quantification method for STP using Volterra modeling.
- To utilize machine learning for classifying compounds based on their effects on neural plasticity.
Main Methods:
- Utilized acute hippocampal slices as a biological substrate for the biosensor.
- Employed random electrical impulse sequences as input and population spike amplitudes as output.
- Quantified STP using first and second-order kernels derived from a Volterra modeling approach.
- Decomposed the second-order kernel into Laguerre functions for feature extraction.
- Inputted kernel features into a single-layer artificial neural network (ANN) for classification.
Main Results:
- The biosensor demonstrated distinct feature profiles for various tested chemical compounds, including picrotoxin, valproate, and carbachol.
- The ANN successfully classified each compound into its respective pharmacological class.
- The Volterra modeling approach proved more specific and time-efficient than conventional methods.
Conclusions:
- The developed tissue-based biosensor effectively screens compounds affecting the nervous system.
- The novel STP quantification and ANN classification provide a robust platform for neuropharmacological assessment.
- This approach offers a rapid and specific method for identifying drug effects on neural function.